Contrary to conventional wisdom, most people with fragile X syndrome express the FMR1 gene — albeit improperly. SourceSource: Spectrum News

But multiple independent researchers say they are not convinced by its results, which fail to confirm high-profile findings from 2017. SourceSource: Spectrum News

This week on social media, researchers discussed sample size in neuroimaging studies and the potential of antisense oligonucleotides to restore the protein lost in fragile X syndrome. SourceSource: Spectrum News

This week on social media, researchers discussed a potential antisense oligonucleotide therapy for fragile X syndrome and sample size in neuroimaging studies. SourceSource: Spectrum News

Here is a roundup of news and research for the week of 3 July. SourceSource: Spectrum News

The discovery could help clinicians diagnose children who carry mutations in the gene, called SCN2A, and gauge their responses to potential therapies. SourceSource: Spectrum News

Zhao says her graduate and postdoctoral training prepared her to transition to her job at the biotech company Ionis Pharmaceuticals, where she works to find treatments for Parkinson’s disease and other conditions. SourceSource: Spectrum News

Nonrandom mating — the propensity for people to partner with others who share their traits — can increase the likelihood of autism or other conditions across generations. SourceSource: Spectrum News

The approach prompts cultured cells to correct the genetic mutation in fragile X syndrome using their own DNA repair system, but still needs to be tested further. SourceSource: Spectrum News

The NIH neurologist talks about her research, her family and how mental health labels can be limiting. SourceSource: Spectrum News

Here is a roundup of news and research for the week of 26 June. SourceSource: Spectrum News

Dentist or doctor visits can overwhelm autistic children with sensory sensitivities. Occupational therapy can help, Stein Duker says. SourceSource: Spectrum News

The framework, inspired by the polygenic risk score, considers the cumulative effect of neuronal connections. SourceSource: Spectrum News

This month’s newsletter looks at the early safety data from the first gene therapy trial for Rett syndrome, among other drug development news. SourceSource: Spectrum News